Cargando…
Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa
The present study aimed to characterize the susceptibility profile of Pseudomonas aeruginosa and Acinetobacter spp. clinical isolates to polymyxin B in a public hospital in Recife-PE, Brazil, between the years of 2018 and 2019, as well as to search for the presence of the mcr-1 gene and evaluate the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441413/ https://www.ncbi.nlm.nih.gov/pubmed/32849907 http://dx.doi.org/10.1155/2020/9852145 |
_version_ | 1783573294267498496 |
---|---|
author | da Costa Júnior, Sérgio Dias da Silva, Wagner Roberto Cirilo da Silva, Adriana Maria Costa Marques Maciel, Maria Amélia Vieira Cavalcanti, Isabella Macário Ferro |
author_facet | da Costa Júnior, Sérgio Dias da Silva, Wagner Roberto Cirilo da Silva, Adriana Maria Costa Marques Maciel, Maria Amélia Vieira Cavalcanti, Isabella Macário Ferro |
author_sort | da Costa Júnior, Sérgio Dias |
collection | PubMed |
description | The present study aimed to characterize the susceptibility profile of Pseudomonas aeruginosa and Acinetobacter spp. clinical isolates to polymyxin B in a public hospital in Recife-PE, Brazil, between the years of 2018 and 2019, as well as to search for the presence of the mcr-1 gene and evaluate the interaction between polymyxin B and usnic acid against these isolates. The strains were identified using the BD Phoenix™ automated system and the agar-spot test was used to determine the susceptibility profile to polymyxin B. The minimum inhibitory concentrations (MICs) of usnic acid and polymyxin B were determined through the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI). Subsequently, Polymerase Chain Reaction (PCR) was performed to detect the mcr-1 gene in the isolates. The interaction between usnic acid and polymyxin B was evaluated by the Checkerboard assay. Among 34 isolates of P. aeruginosa, 26.5% (9/34) were positive for the polymyxin B agar-spot test, and 11.8% (4/34) presented an intermediate susceptibility (MIC = 4 μg/mL), while 14.7% (5/34) presented antimicrobial resistance with MIC values ranging from 8 to 32 μg/mL. Among 38 isolates of Acinetobacter spp., 13.2% (5/38) were positive for the polymyxin B agar-spot test and all of them were resistant to polymyxin B with a MIC value > 32 μg/mL. The mcr-1 gene was not detected in the clinical isolates. Regarding usnic acid, it presented a moderate antibacterial activity against two P. aeruginosa isolates (MIC = 250 μg/mL) and no activity was detected against the others. A synergistic effect between usnic acid and polymyxin B was observed against three clinical isolates of P. aeruginosa which were resistant to polymyxin B (FICI ≤ 0.5). Therefore, it was possible to observe that usnic acid is a promising candidate to be used in combination with polymyxin B against infections caused by resistant P. aeruginosa. |
format | Online Article Text |
id | pubmed-7441413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-74414132020-08-25 Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa da Costa Júnior, Sérgio Dias da Silva, Wagner Roberto Cirilo da Silva, Adriana Maria Costa Marques Maciel, Maria Amélia Vieira Cavalcanti, Isabella Macário Ferro Evid Based Complement Alternat Med Research Article The present study aimed to characterize the susceptibility profile of Pseudomonas aeruginosa and Acinetobacter spp. clinical isolates to polymyxin B in a public hospital in Recife-PE, Brazil, between the years of 2018 and 2019, as well as to search for the presence of the mcr-1 gene and evaluate the interaction between polymyxin B and usnic acid against these isolates. The strains were identified using the BD Phoenix™ automated system and the agar-spot test was used to determine the susceptibility profile to polymyxin B. The minimum inhibitory concentrations (MICs) of usnic acid and polymyxin B were determined through the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI). Subsequently, Polymerase Chain Reaction (PCR) was performed to detect the mcr-1 gene in the isolates. The interaction between usnic acid and polymyxin B was evaluated by the Checkerboard assay. Among 34 isolates of P. aeruginosa, 26.5% (9/34) were positive for the polymyxin B agar-spot test, and 11.8% (4/34) presented an intermediate susceptibility (MIC = 4 μg/mL), while 14.7% (5/34) presented antimicrobial resistance with MIC values ranging from 8 to 32 μg/mL. Among 38 isolates of Acinetobacter spp., 13.2% (5/38) were positive for the polymyxin B agar-spot test and all of them were resistant to polymyxin B with a MIC value > 32 μg/mL. The mcr-1 gene was not detected in the clinical isolates. Regarding usnic acid, it presented a moderate antibacterial activity against two P. aeruginosa isolates (MIC = 250 μg/mL) and no activity was detected against the others. A synergistic effect between usnic acid and polymyxin B was observed against three clinical isolates of P. aeruginosa which were resistant to polymyxin B (FICI ≤ 0.5). Therefore, it was possible to observe that usnic acid is a promising candidate to be used in combination with polymyxin B against infections caused by resistant P. aeruginosa. Hindawi 2020-08-12 /pmc/articles/PMC7441413/ /pubmed/32849907 http://dx.doi.org/10.1155/2020/9852145 Text en Copyright © 2020 Sérgio Dias da Costa Júnior et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article da Costa Júnior, Sérgio Dias da Silva, Wagner Roberto Cirilo da Silva, Adriana Maria Costa Marques Maciel, Maria Amélia Vieira Cavalcanti, Isabella Macário Ferro Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa |
title | Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa |
title_full | Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa |
title_fullStr | Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa |
title_full_unstemmed | Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa |
title_short | Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa |
title_sort | synergistic effect between usnic acid and polymyxin b against resistant clinical isolates of pseudomonas aeruginosa |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441413/ https://www.ncbi.nlm.nih.gov/pubmed/32849907 http://dx.doi.org/10.1155/2020/9852145 |
work_keys_str_mv | AT dacostajuniorsergiodias synergisticeffectbetweenusnicacidandpolymyxinbagainstresistantclinicalisolatesofpseudomonasaeruginosa AT dasilvawagnerrobertocirilo synergisticeffectbetweenusnicacidandpolymyxinbagainstresistantclinicalisolatesofpseudomonasaeruginosa AT dasilvaadrianamariacostamarques synergisticeffectbetweenusnicacidandpolymyxinbagainstresistantclinicalisolatesofpseudomonasaeruginosa AT macielmariaameliavieira synergisticeffectbetweenusnicacidandpolymyxinbagainstresistantclinicalisolatesofpseudomonasaeruginosa AT cavalcantiisabellamacarioferro synergisticeffectbetweenusnicacidandpolymyxinbagainstresistantclinicalisolatesofpseudomonasaeruginosa |